PO.PS01.05 · 人群科学

与乳腺癌亚型风险相关的生殖因素:来自南方社区队列研究的发现

Reproductive factors associated with breast cancer risk by subtypes: Findings from the Southern Community Cohort Study

编号 2343 展板 9 时间 4/20 09:00–12:00 区域 Section 36 主讲 Rajat Das Gupta, MBBS;MPH;PhD
分会场 Epidemiology: Cancer Incidence, Mortality, Patterns, and Methodology
该海报暂无可下载的资料 AACR 官方页面

作者与单位 Authors & Affiliations

Rajat Das Gupta, Wanqing Wen, Wei Zheng

Medicine, Vanderbilt University Medical Center, Nashville, TN

摘要 Abstract

中文摘要
背景: 乳腺癌是美国女性中最常见的癌症。生殖因素可能通过因分子亚型而异的激素途径影响乳腺癌病因。我们在南方社区队列研究中调查了生殖因素与各乳腺癌亚型风险之间的关联。 方法: 在排除随访第一年以最大程度减少潜在的反向因果关系后,42,922 名 40-79 岁女性(69.2% 为黑人)纳入研究。队列成员随访长达 213 个月。乳腺癌病例按雌激素受体(ER)、孕激素受体(PR)和人表皮生长因子受体 2(HER2)状态分类为管腔 A 样(ER/PR+,HER2-)、管腔 B 样(ER/PR+,HER2+)、HER2 富集型(ER/PR-,HER2+)和三阴性乳腺癌(TNBC;ER/PR/HER2-)。为考虑竞争风险,使用病因特异性 Cox 比例风险模型估计生殖因素与各乳腺癌亚型关联的风险比(HR)和 95% 置信区间(CI)。模型校正了年龄、入组来源、教育、种族、收入、乳腺癌家族史、乳腺囊肿或纤维瘤个人史、吸烟、饮酒、体重指数、闲暇时间体力活动、健康饮食指数以及是否曾使用口服避孕药和激素替代疗法。在黑人女性中进行了亚组分析。我们使用 Fine-Gray 亚分布风险模型重复了上述分析。 结果: 随访期间共发生 1,257 例乳腺癌(管腔 A 样=612;管腔 B 样=105;HER2 富集型=62;TNBC=180;未分类=298)。在整个队列中,多产,尤其是 ≥3 次生育,与管腔 A 样(HR=0.74;95% CI:0.57-0.96)和管腔 B 样(HR=0.53;95% CI:0.30-0.94)亚型呈负相关,但与 ER-/PR- 疾病呈正相关(HR=1.71;95% CI:1.06-2.77)。在黑人女性中,其还与 TNBC 呈正相关(HR=2.30;95% CI:1.12-4.72)。在经产妇中,首次活产年龄 ≥30 岁与较高的 ER+/PR+ 风险相关(HR=1.59;95% CI:1.05-2.40),但与较低的 ER-/PR- 乳腺癌风险相关(HR=0.25;95% CI:0.08-0.76)。Fine-Gray 模型显示与病因特异性模型一致的结果。 结论: 产次和首次生育年龄与乳腺癌风险呈亚型特异性关联。多产与管腔型乳腺癌亚型风险降低相关,但与 ER−/PR− 肿瘤风险升高相关。首次生育年龄较晚与 ER+/PR+ 疾病风险升高及 ER−/PR− 亚型风险降低相关。这些发现凸显了按激素受体状态划分的病因异质性,并强调了将生殖史纳入亚型特异性风险预测和预防策略的重要性。
查看英文原文 English abstract
Background: Breast cancer is the most common cancer among U.S. women. Reproductive factors may influence breast cancer etiology through hormonal pathways that differ by molecular subtypes. We investigated the associations between reproductive factors and breast cancer risk by subtypes in the Southern Community Cohort Study. Methods: After excluding the first year of follow-up to minimize potential reverse causation, 42,922 women aged 40-79 years (69.2% Black) remained for the study. Cohort members were followed for up to 213 months. Breast cancer cases were classified by estrogen receptor (ER), progesterone receptor (PR), and human epidermal growth factor receptor 2 (HER2) status as luminal A-like (ER/PR+, HER2-), luminal B-like (ER/PR+, HER2+), HER2-enriched (ER/PR-, HER2+), and triple-negative breast cancer (TNBC; ER/PR/HER2-). To account for competing risk, cause-specific Cox proportional hazards models were used to estimate hazard ratios (HRs) and 95% confidence intervals (CIs) for associations between reproductive factors and each breast cancer subtypes. Models were adjusted for age, enrollment source, education, race, income, family history of breast cancer, personal history of breast cysts or fibroids, smoking, alcohol intake, body mass index, leisure-time physical activity, healthy eating index, and ever use of oral contraceptive pills and hormone replacement therapy. Subgroup analyses were conducted among Black women. We repeated the above analyses using Fine-Gray subdistribution hazard models. Results: Over follow-up, 1,257 breast cancers occurred (luminal A-like = 612; luminal B-like = 105; HER2-enriched = 62; TNBC = 180; unclassified = 298). In the overall cohort, multiparity, particularly ≥3 births, was inversely associated with luminal A-like (HR = 0.74; 95% CI: 0.57-0.96) and luminal B-like (HR = 0.53; 95% CI: 0.30-0.94) subtypes, but positively with ER-/PR- disease (HR = 1.71; 95% CI: 1.06-2.77). Among Black women, it was also positively associated with TNBC (HR = 2.30; 95% CI: 1.12-4.72). Among parous women, first live birth at ≥ 30 years was associated with a higher risk of ER+/PR+ (HR = 1.59; 95% CI: 1.05-2.40) but a lower risk of ER-/PR- (HR = 0.25; 95% CI: 0.08-0.76) breast cancer. Fine-Gray models showed consistent results with cause-specific models. Conclusions: Parity and age at first birth demonstrate subtype-specific associations with breast cancer risk. Multiparity is associated with a reduced risk of luminal breast cancer subtypes but an increased risk of ER−/PR− tumors. A later age at first childbirth is associated with an increased risk of ER+/PR+ disease and a decreased risk of ER−/PR− subtypes. These findings highlight etiologic heterogeneity by hormonal receptor status and underscore the importance of incorporating reproductive history in subtype-specific risk prediction and prevention strategies.
利益披露 Disclosure
R. Gupta, None.. W. Wen, None.. W. Zheng, None.

← 返回 AACR 2026 检索